Principal Financial Group Inc. Sells 12,781 Shares of agilon health, inc. (NYSE:AGL)

Principal Financial Group Inc. cut its position in agilon health, inc. (NYSE:AGL) by 30.7% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 28,894 shares of the company’s stock after selling 12,781 shares during the quarter. Principal Financial Group Inc.’s holdings in agilon health were worth $114,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of AGL. J.Safra Asset Management Corp grew its position in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock worth $27,000 after buying an additional 3,625 shares during the last quarter. City State Bank acquired a new stake in agilon health in the 3rd quarter worth approximately $52,000. CWM LLC grew its position in agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after purchasing an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC acquired a new position in agilon health during the 2nd quarter valued at approximately $60,000. Finally, Allspring Global Investments Holdings LLC raised its holdings in shares of agilon health by 17,790.0% in the second quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock worth $70,000 after buying an additional 10,674 shares during the last quarter.

agilon health Price Performance

agilon health stock opened at $2.05 on Wednesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The business has a fifty day moving average of $2.86 and a two-hundred day moving average of $4.72. agilon health, inc. has a one year low of $1.50 and a one year high of $13.76. The company has a market cap of $844.64 million, a P/E ratio of -2.18 and a beta of 0.60.

agilon health (NYSE:AGL) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period in the prior year, the firm earned ($0.06) EPS. As a group, analysts predict that agilon health, inc. will post -0.47 earnings per share for the current fiscal year.

Insider Transactions at agilon health

In related news, CEO Steven Sell acquired 20,000 shares of agilon health stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. This trade represents a 42.03 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.20% of the company’s stock.

Analyst Ratings Changes

AGL has been the topic of a number of research analyst reports. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Deutsche Bank Aktiengesellschaft reduced their price target on agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Barclays dropped their price objective on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. JMP Securities lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. Finally, TD Cowen cut their price target on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a report on Monday, November 11th. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $6.05.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.